Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
1.010
+0.010 (1.00%)
At close: Nov 21, 2024, 4:00 PM
1.030
+0.020 (1.98%)
After-hours: Nov 21, 2024, 5:01 PM EST
Nektar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 186 | 108 | 425 | 2,493 | 3,050 | 3,797 | |
| Market Cap Growth | 111.33% | -74.63% | -82.96% | -18.24% | -19.69% | -33.26% | |
| Enterprise Value | 142 | -20 | 179 | 1,866 | 2,117 | 2,547 | |
| Last Close Price | 1.00 | 0.56 | 2.26 | 13.51 | 17.00 | 21.59 | |
| PS Ratio | 2.16 | 1.20 | 4.61 | 24.47 | 19.94 | 33.13 | |
| PB Ratio | 3.77 | 0.82 | 1.16 | 3.67 | 2.83 | 2.70 | |
| P/TBV Ratio | 4.90 | 0.82 | 1.46 | 4.13 | 3.05 | 2.86 | |
| EV/Sales Ratio | 1.52 | - | 1.94 | 18.31 | 13.84 | 22.22 | |
| Debt / Equity Ratio | 4.22 | 1.76 | 0.78 | 0.50 | 0.33 | 0.34 | |
| Asset Turnover | 0.25 | 0.16 | 0.10 | 0.08 | 0.09 | 0.06 | |
| Inventory Turnover | - | 1.91 | 1.24 | 1.60 | 1.39 | 1.78 | |
| Quick Ratio | 3.65 | 5.97 | 7.53 | 8.89 | 9.55 | 3.87 | |
| Current Ratio | 4.24 | 6.45 | 8.00 | 9.34 | 9.83 | 4.02 | |
| Return on Equity (ROE) | -161.63% | -110.95% | -70.39% | -59.64% | -35.80% | -28.22% | |
| Return on Assets (ROA) | -22.64% | -15.25% | -16.43% | -21.00% | -13.51% | -13.33% | |
| Return on Capital (ROIC) | -25.77% | -16.65% | -17.96% | -22.80% | -14.33% | -13.99% | |
| Earnings Yield | -90.34% | -256.12% | -86.68% | -21.01% | -14.57% | -11.60% | |
| FCF Yield | -95.44% | -179.50% | -72.90% | -17.15% | -10.51% | -9.35% | |
| Buyback Yield / Dilution | -6.17% | -1.53% | -2.09% | -2.64% | -2.05% | 2.85% | |
| Total Shareholder Return | -6.17% | -1.53% | -2.09% | -2.64% | -2.05% | 2.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.